RiLipo™ Liposomal Vitamin C



About RiLipo™ Liposomal Vitamin C

RiLipo™ Liposomal Vitamin C is a 70% high-potency Vitamin C ingredient developed with advanced phospholipid-based liposomal delivery technology. By combining high Vitamin C content with a verified liposomal delivery system, RiLipo™ is designed to support more efficient Vitamin C absorption and bioavailability. From liposomal structure characterization to bioavailability evaluation, its performance is supported by scientific validation, providing a high-performance ingredient solution for modern nutritional formulations. RiLipo™ is available in a stable powder format and can be flexibly applied to powdered drinks, direct-to-consume powders, tablets, hard capsules, and other nutritional products.

Why choose RiLipo™ Liposomal Vitamin C

True Liposomal Structure

Verified through particle size, zeta potential, and electron microscopy characterization.
70% High-Potency Vitamin C

Combines high Vitamin C content with advanced liposomal delivery for high-dose nutritional formulations.
Designed for Enhanced Bioavailability

Liposomal delivery provides an alternative pathway to conventional water-soluble Vitamin C, designed for more efficient absorption and utilization.
Science-Verified Performance

From structural characterization to animal and human studies, RiLipo™ is supported by a multi-level scientific evidence base.
Stable Powder, Flexible Formulation

A stable powder format enables flexible applications across powdered drinks, direct-to-consume powders, tablets, and hard capsules.

Frequently Asked Questions About RiLipo Liposomal Vitamin C

Is your Vitamin C ingredient a true liposomal product?

Yes. RiLipo™ Liposomal Vitamin C is evaluated as a liposomal delivery system based on multiple structural and performance characteristics, including particle size, morphology, phospholipid bilayer characteristics, encapsulation efficiency, and stability.

How do you verify that a true liposomal structure has been formed?

RiLipo™ is characterized using multiple analytical methods, including TEM/Cryo-TEM for morphology, particle size and PDI analysis, Zeta potential, encapsulation efficiency, and bioavailability data. These complementary results provide a comprehensive basis for evaluating liposomal structure and delivery performance.

Does having a liposomal structure mean that Vitamin C is successfully encapsulated?

Not necessarily. Electron microscopy can provide evidence of a lipid carrier-like structure, but the extent of encapsulation needs to be evaluated using additional parameters such as encapsulation efficiency and loading capacity. Therefore, liposomal structure and encapsulation should be assessed separately.

What is the encapsulation efficiency of RiLipo™ Liposomal Vitamin C?

Encapsulation efficiency should be evaluated based on a clearly defined analytical method and calculation methodology. The evaluation should consider encapsulation efficiency together with total Vitamin C content and loading capacity to provide a more complete assessment of the liposomal delivery system.

Does liposomal Vitamin C always provide better absorption than conventional Vitamin C?

Not necessarily. Liposomal delivery has the technical potential to improve dispersion, protect the active ingredient, and support delivery. However, any actual advantage in absorption or bioavailability should be demonstrated through product-specific animal pharmacokinetic (PK) studies or human clinical research.

Is RiLipo™ Liposomal Vitamin C stable, and can Vitamin C leak from the liposomes?

Liposomal stability should be evaluated based on product-specific stability data. Key parameters may include changes in particle size, morphology, encapsulation efficiency, active ingredient content, and overall system stability during storage. These data help assess whether the liposomal structure remains stable and whether significant leakage occurs over time.

What dosage forms can RiLipo™ Liposomal Vitamin C be applied to?

RiLipo™ is available in a stable powder format and can be developed for a range of nutritional dosage forms, including powdered drinks, direct-to-consume powders, tablets, and hard capsules. Specific applications should be evaluated based on formulation requirements and application testing.

Is liposomal Vitamin C compliant with applicable regulations, and can it be promoted as having ‘high absorption’?

Claims should be supported by appropriate product evidence and comply with applicable regulatory requirements. The term ‘liposomal’ should be supported by evidence demonstrating the relevant product structure. Claims regarding enhanced absorption or bioavailability should be supported by corresponding scientific data, such as appropriate animal pharmacokinetic or human clinical studies.

What value does RiLipo™ offer compared with conventional Vitamin C or other liposomal products?

The value of a liposomal Vitamin C ingredient should be evaluated based on more than its price. Key considerations include protection of the active ingredient, delivery and absorption performance, formulation performance, and stability. RiLipo™ is designed to provide value through its liposomal delivery system, high Vitamin C content, structural characterization, and performance validation.